Pharma Marketing Network

APRIL 4, 2025

This article explores the evolving role of referral marketing in pharma, unpacking its mechanics, benefits, compliance considerations, and future outlook. On the patient side, pharmaceutical companies have launched ambassador and mentorship programs. How do pharma companies use referral marketing?

HIPAA 52

HIPAA Pharmaceutical Companies Pharmaceutical Companies FDA 52

pharmaphorum

JANUARY 16, 2023

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. Innovation will power the market. Difficile treatment, Ser-109.

FDA 98

FDA Pharmaceutical Companies Pharmaceutical Companies Compounding 98

The Checkup by Singlecare

MARCH 10, 2025

The medication is available in both brand-name and compounded forms, although the compounded forms are not FDA approved. Compounded semaglutide is made by special compounding pharmacies rather than pharmaceutical companies. In this article, well take a closer look at semaglutide, its costs, and alternatives that may be offered.

Compounding 52

Compounding Insurance Insurance Coverage FDA 52

Pharma Marketing Network

MARCH 10, 2025

This article explores how to develop and optimize paid social media campaigns that drive engagement while staying compliant. Disease awareness campaigns can also reach specific patient groups based on demographics and interests, helping pharmaceutical companies create more personalized outreach. In the U.S.,

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharma Marketing Network

FEBRUARY 27, 2025

In this article, well dive into key pharma digital marketing strategies that can help pharma brands connect with healthcare professionals (HCPs), patients, and stakeholders effectively. Using FDA-approved messaging and ensuring transparent disclaimers are critical in avoiding regulatory issues. However, compliance is key.

HIPAA 52

HIPAA FDA Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

MAY 3, 2023

However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information. In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

pharmaphorum

MAY 13, 2022

In my last article, I outlined the inflection point facing the pharmaceutical industry in digital health and the digital transformation of its clinical and commercial operations. This time I’m going to focus on one company and its view on pharma’s digital commercial strategy. Digital fluency and change.

Pharmaceutical Companies 131

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 131

European Pharmaceutical Review

SEPTEMBER 22, 2022

This article will explore the advantages of using HCs, as well as several considerations for their effective use, including scientific methodology and regulatory guidance. Dr Maier has over 25 years of experience in drug development and commercialisation at pharmaceutical companies in Europe, Canada, the United States and Asia.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies FDA Documentation 122

European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. Letter to FDA, 06 July 2022.

FDA 96

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 96

ISPE

NOVEMBER 2, 2022

Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. President, U.S. Business Unit and U.S. Country Head.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

Pharma Marketing Network

OCTOBER 3, 2024

In the digital age, content creation for social media has become an indispensable tool for industries across the board, including pharmaceuticals. As the healthcare landscape evolves, pharmaceutical companies are increasingly leveraging social media platforms to connect with healthcare professionals, patients, and the broader public.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 52

Pharma Marketing Network

APRIL 1, 2023

One of the key areas of expertise for Pharma-Mkting.com is pharmaceutical marketing. They provide a comprehensive range of services and resources to help pharmaceutical companies reach their target audience and achieve their marketing goals. This article was produced with the assistance of artificial intelligence.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

European Pharmaceutical Review

AUGUST 23, 2022

The US Food and Drug Administration (FDA) further estimates that 97 percent of online pharmacies are operating illegally. Second, pharmaceutical companies can implement serialisation of individual medicines, potentially tracking and tracing medicines to ensure brand protection. About the author.

Dosage 98

Dosage Packaging Pharmaceutical Companies Pharmaceutical Companies 98

Pharma Marketing Network

OCTOBER 6, 2021

This is an especially tough predicament for pharmaceutical companies given the need to target very specific audiences while maintaining reach. For pharmaceutical companies, this need is even more pressing. Premium Placement Quality Allows Creative to Shine.

HIPAA 98

HIPAA Pharmaceutical Companies Pharmaceutical Companies FDA 98

pharmaphorum

SEPTEMBER 18, 2020

“Picking the next merger candidate is hard enough, doing so before everyone else jumps on board, then picking the right time to sell makes for a dangerous investment game,” said one BBC News article from December 1998. However, this new name has since caused confusion between Prilosec and Prozac. Blockbusters go off patent.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 116

Pharma Marketing Network

MARCH 23, 2023

The Food and Drug Administration (FDA) has recently approved a new drug for the treatment of Alzheimer’s disease called Leqembi. In recent years, several drugs for Alzheimer’s have been developed, but none have been able to gain approval from the FDA. FDA Approves Leqembi for the Treatment of Alzheimer’s Disease.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

JULY 10, 2023

Pharmaceutical marketing is the process of communicating the benefits of a pharmaceutical product to potential patients and healthcare providers. It can be a complex and challenging process, as pharmaceutical companies must adhere to strict regulations while also developing creative and effective marketing campaigns.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 40

European Pharmaceutical Review

OCTOBER 20, 2022

The US Food and Drug Administration (FDA) defines eight different types of water: non-potable, potable (drinkable), purified, water for injection (WFI), sterile water for injection, sterile water for inhalation, bacteriostatic water for injection and sterile water for irrigation. 7 also in the scheme of microbial monitoring.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

The Checkup by Singlecare

APRIL 19, 2024

Farxiga is an oral prescription drug containing the active ingredient dapagliflozin and made by the pharmaceutical company AstraZeneca. The initial FDA approval of Farxiga for heart failure was for people with heart failure with a reduced ejection fraction. It is classified as a sodium-glucose cotransporter 2 (SGLT2) inhibitor.

Insurance 98

Insurance Dosage Hospitals FDA 98

Pharma Marketing Network

OCTOBER 3, 2024

Pharmaceutical marketing is not just about reaching healthcare professionals and patients; it involves a complex interplay of understanding market dynamics, regulatory compliance, and leveraging digital platforms. Failure to comply with these regulations can result in severe penalties, including fines and reputational damage.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 52

pharmaphorum

JANUARY 9, 2023

This article is the first part of three and covers the first three of nine predictions, here focusing on global healthcare environmental challenges and what they mean for the pharmaceutical industry. More remains to be addressed, and not just by conventional pharmaceutical companies. Pharma’s starting to wake up to this.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

ISPE

NOVEMBER 1, 2022

The first keynote speaker was Michael Kopcha, PhD, RPh, Director of the Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US FDA. He presented on “Quality: A Key Ingredient for Stable Pharmaceutical Supply Chains.”. Director, Office of Pharmaceutical Quality. Tue, 11/01/2022 - 06:49.

FDA 98

FDA Insurance Chemotherapy Documentation 98

pharmaphorum

JANUARY 5, 2021

For pharmaceutical companies there are a number of implications. For pharmaceutical companies, this may mean a change in patient journeys to pharmacotherapy becoming longer and more complex, but also occurring in different settings. It will take a decade to fully evaluate the true impact. The non COVID-19 patient backlog.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

SEPTEMBER 30, 2022

This means that drugs such as Keytruda, which has received almost 40 FDA approvals since its launch, can offer significant volume-based rebates. The Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies; law firms; regulatory agencies; and national and international industry associations.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

Pharma Marketing Network

MAY 11, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. Food and Drug Administration (FDA) in June 2021. 2021, June 7). Retrieved from [link] · What is Alzheimer’s disease?

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

European Pharmaceutical Review

APRIL 10, 2024

The recent FDA approvals of two microbiome products in the US, in November 2022 and April 2023, 1-2 represent a significant milestone, maturing the industry and paving the way for advancement and regulatory clearance of additional microbiome products in broader indications. Internet] Pharmaceutical Technology. cited 2024Feb].

Immunization 95

Immunization Chemotherapy FDA Pharmaceutical Companies 95

PharmaShots

JUNE 6, 2023

The article focuses on the integration of automation with Artificial Intelligence (AI) and Machine Learning (ML). This article provides an informative account of intelligent automation, the key differences between AI & ML, their importance, and a potent eight-step roadmap to implementation. With the impelling Pharma 4.0,

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Mayo Clinic Data Entry 40

European Pharmaceutical Review

NOVEMBER 15, 2022

This article primarily discusses Appendix D5 Testing of Computerized Systems and Appendix M12 Critical Thinking. FDA, Computer Software Assurance for Production and Quality System Software – Draft Guidance. FDA, 2022. . The GAMP 5 Second Edition includes: Six completely new appendices. About the authors.

Documentation 98

Documentation FDA Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

SEPTEMBER 2, 2022

This article explores just one aspect of the RMP, that of RMMs, and how their effectiveness is measured with Dr Sophie Jouaville, an associate principal at IQVIA working on the design and oversight of non-interventional real-world evidence (RWE) safety and health economics and outcomes research (HEOR) studies.

Adverse Reactions 96

Adverse Reactions Documentation Medical Schools Packaging 96

The Checkup by Singlecare

APRIL 16, 2024

It is a biologic medication and monoclonal antibody made by the pharmaceutical company Janssen Biotech. Stelara is an injectable prescription drug containing the active ingredient ustekinumab. Stelara works by blocking proteins in the immune system that cause inflammation.

Dosage 98

Dosage Vaccines Immunization Insurance 98

pharmaphorum

OCTOBER 3, 2022

NB: in Part I of this article, notions of lower-pricing intentionality and comparative global opportunities were explored. The Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies; law firms; regulatory agencies; and national and international industry associations.

Chemotherapy 98

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies FDA 98

The People's Pharmacy

JUNE 12, 2023

The parties that benefit are the pharmaceutical companies and the pharmacies. The losers are patients, insurance companies and the country as a whole for wasting money on unneeded things. If a patient wants to report an adverse reaction to the FDA, they need to fill out Form 3500B. The FDA does virtually no testing.

Labelling 62

Labelling Mail-Order Pharmacies Adverse Reactions FDA 62

Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. Food and Drug Administration (FDA) in June 2021.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA Vaccines 52

pharmaphorum

MARCH 19, 2021

Pharmaceutical companies have long taken notice of this opportunity, developing a wave of therapies that are now entering the market. FDA data indicates that while the number of orphan designations has been increasing over the last half-decade, the number of unique indications has been decreasing 3.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharma Marketing Network

OCTOBER 1, 2024

This article provides a comprehensive overview of the various facets of pharmaceutical marketing, from its historical evolution to future trends. By understanding these strategies, stakeholders in the pharmaceutical industry can better navigate the complexities of promoting their products effectively.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies FDA 52

Viseven

DECEMBER 4, 2024

This article will discuss pharmaceutical validation, its benefits, types, and basic recommendations. By adhering to critical process parameters (CPPs), pharmaceutical companies can avoid legal and financial risks while building trust with patients in the safety and reliability of their products. Keep on reading!

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies FDA 52

The People's Pharmacy

MAY 4, 2023

The drug lecanemab ( Leqembi ) was recently approved by the FDA to treat early Alzheimer’s disease. Pharmaceutical companies do not know what to make of this unexpected complication. is moderate dementia and a score of 16-18 is really severe Alzheimer’s disease. Put another way, the lower the score the better.

Nursing Homes 65

Nursing Homes Pharmaceutical Companies Pharmaceutical Companies FDA 65